Get the Stockscreener App
13.28
2.00%
0.26
Conexeu Sciences Inc stock is traded at $13.28, with a volume of 36,150.
It is up +2.00% in the last 24 hours and up +0.00% over the past month.
Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.
See More
Previous Close:
$13.02
Open:
$13.21
24h Volume:
36,150
Relative Volume:
1.40
Market Cap:
$355.35M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.48%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$12.05
$13.50
1-Week Range:
$9.60
$13.82
52-Week Range:
$9.60
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
Name
Conexeu Sciences Inc
Sector
Industry
Phone
604-315-4722
Address
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
13.28 | 355.35M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Conexeu Sciences Inc Stock (CNXU) Latest News
Is Conexeu Sciences (CNXU) Quietly Redefining Its Commercial Ambitions With CXU Platform Moves? - Yahoo Finance
Conexeu Sciences Inc. (CNXU) Cash From Financing (TTM) - Zacks Investment Research
Krystal Biotech (KRYS) Revenue Growth Puts VYJUVEK Pipeline Progress In Focus - simplywall.st
How Investors Are Reacting To Conexeu Sciences (CNXU) Bolstering Leadership For CXU Device Commercialization - simplywall.st
Latest CNXU ETF News Today | Earnings, Events & Price Alerts - Intellectia AI
CNXU Technical Analysis & ETF Price Forecast - Intellectia AI
Analysts Have Lowered Expectations For Comtech Telecommunications Corp. (NASDAQ:CMTL) After Its Latest Results - simplywall.st
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower - Investing News Network
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It - The Manila Times
Conexeu builds board as regenerative tissue ambitions widen - The Pharma Letter
Conexeu Sciences Inc. 2026 Q2 10-Q Report: Financials, Risks, and Company Overview - Minichart
Conexeu Sciences Inc. 3Q 2026: Revenue $0 Net loss $2.3M, EPS $(0.11) — 10-Q Summary - TradingView
CNXU: Board expanded to nine, with updated director compensation and new CCO agreement featuring equity awards - TradingView
Conexeu Sciences expands board, names chief commercial officer By Investing.com - Investing.com South Africa
Conexeu Sciences Inc. Announces Management and Committee Changes, Effective June 15, 2026 - marketscreener.com
Conexeu Sciences expands board, names chief commercial officer - Investing.com
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing - The Manila Times
Conexeu Sciences (CNXU) 10K Form and Latest SEC Filings 2026 - MarketBeat
CONEXEU SCIENCES INC (CNXU) Stock Chart - ChartMill
Top Conexeu Sciences (CNXU) Competitors 2026 - MarketBeat
Conexeu Sciences Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Conexeu Sciences Inc. Rings the Closing Bell - Nasdaq
MC_061026_tower-shot.jpg - Nasdaq
A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus - GlobeNewswire
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program - The National Law Review
Conexeu Sciences Inc. Reports Manufacturing Scale Up And Regulatory Progress For Lead CXU Wound Care Program - marketscreener.com
Conexeu Sciences stock gains on wound care device progress By Investing.com - Investing.com South Africa
Conexeu Sciences stock gains on wound care device progress - Investing.com
Conexeu Sciences provides update on manufacturing scale up for wound care device - TipRanks
Conexeu advances manufacturing for wound care device ahead of 2027 FDA filing - Investing.com
Flowable gel for complex wounds readied for 2027 FDA 510(k) bid - Stock Titan
The Body as Blueprint - lifehealth.com
Top SkyAI, Inc. Warrant (SKYAW) Competitors 2026 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
2026 Special Olympics USA Games Rings the Nasdaq Stock Market Closing Bell - Nasdaq
CNXU Technical Analysis | Trend, Signals & Chart Patterns | CONEXEU SCIENCES INC (NASDAQ:CNXU) - ChartMill
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early - Investing.com
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early - sharewise.com
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026 - The Manila Times
Top Inspira Technologies OXY B.H.N. (QTEX) Competitors 2026 - MarketBeat
Conexeu Sciences (CNXU) Stock Price, News & Analysis - MarketBeat
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - marketscreener.com
How Investors Are Reacting To Conexeu Sciences (CNXU) 3D-Printed Bioregenerative Breast Matrix Initiative - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch - RTTNews
Assessing Conexeu Sciences (CNXU) Valuation After Launch Of Preclinical B.R.E.A.S.T. Program - simplywall.st
Conexeu Sciences Inc Stock (CNXU) Financials Data
There is no financial data for Conexeu Sciences Inc (CNXU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
1.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):